Bob Hombach

Bob Hombach is a retired CFO and COO with 27 years of financial and operational leadership experience in the healthcare sector. They currently serve on the boards of BioMarin, embecta, Seaport Therapeutics, and Henry Schein, and have previously held board positions at Aptinyx and CarMax. Hombach's notable past roles include Executive Vice President, CFO, and COO at Baxalta, where they played a crucial role in the company's launch and subsequent merger with Shire PLC. They hold an MBA from Northwestern University and a BS in Finance from the University of Colorado Boulder, along with CPA and CMA certifications. Recognized by IR Magazine as a Top 100 US CFO, Hombach has demonstrated expertise in finance, M&A, and corporate strategy.